These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cholelithiasis and acromegaly: therapeutic strategies. Montini M; Gianola D; Pagani MD; Pedroncelli A; Caldara R; Gherardi F; Bonelli M; Lancranjan I; Pagani G Clin Endocrinol (Oxf); 1994 Mar; 40(3):401-6. PubMed ID: 8187305 [TBL] [Abstract][Full Text] [Related]
4. Prospective study of the long-term effects of somatostatin analog (octreotide) on gallbladder function and gallstone formation in Chinese acromegalic patients. Shi YF; Zhu XF; Harris AG; Zhang JX; Dai Q J Clin Endocrinol Metab; 1993 Jan; 76(1):32-7. PubMed ID: 8421099 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study. Newman CB; Melmed S; Snyder PJ; Young WF; Boyajy LD; Levy R; Stewart WN; Klibanski A; Molitch ME; Gagel RF J Clin Endocrinol Metab; 1995 Sep; 80(9):2768-75. PubMed ID: 7673422 [TBL] [Abstract][Full Text] [Related]
6. Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly. Ewins DL; Javaid A; Coskeran PB; Shah S; Butler J; Deprez PH; Miell J; Calam J; Barrett JJ; Dawson JM Q J Med; 1992 Apr; 83(300):295-306. PubMed ID: 1631261 [TBL] [Abstract][Full Text] [Related]
7. Octreotide-associated biliary tract dysfunction and gallstone formation: pathophysiology and management. Redfern JS; Fortuner WJ Am J Gastroenterol; 1995 Jul; 90(7):1042-52. PubMed ID: 7611194 [TBL] [Abstract][Full Text] [Related]
8. [Prospective study of functional changes in the gallbladder and formation of gallstones induced by long-term treatment of somatostatin analogue SMS201-995 in patients of active acromegaly]. Zhu XF; Shi YF; Zhang JX Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):405-8, 455. PubMed ID: 1752152 [TBL] [Abstract][Full Text] [Related]
13. Gallbladder function in acromegalic patients taking long-term octreotide: evidence of rebound hypermotility on cessation of treatment. Rhodes M; James RA; Bird M; Clayton B; Kendall-Taylor P; Lennard TW Scand J Gastroenterol; 1992; 27(2):115-8. PubMed ID: 1561523 [TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of acromegaly with a long-acting analogue of somatostatin, octreotide. Page MD; Millward ME; Taylor A; Preece M; Hourihan M; Hall R; Scanlon MF Q J Med; 1990 Feb; 74(274):189-201. PubMed ID: 2111918 [TBL] [Abstract][Full Text] [Related]
15. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. Hussaini SH; Murphy GM; Kennedy C; Besser GM; Wass JA; Dowling RH Gastroenterology; 1994 Nov; 107(5):1503-13. PubMed ID: 7926514 [TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and tolerability of octreotide treatment in acromegaly. Christensen SE; Weeke J; Orskov H; Kaal A; Lund E; Jørgensen J; Harris AG Metabolism; 1992 Sep; 41(9 Suppl 2):44-50. PubMed ID: 1518433 [TBL] [Abstract][Full Text] [Related]
17. Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR. Moschetta A; Stolk MF; Rehfeld JF; Portincasa P; Slee PH; Koppeschaar HP; Van Erpecum KJ; Vanberge-Henegouwen GP Aliment Pharmacol Ther; 2001 Feb; 15(2):181-5. PubMed ID: 11148435 [TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly. Plöckinger U; Dienemann D; Quabbe HJ J Clin Endocrinol Metab; 1990 Dec; 71(6):1658-62. PubMed ID: 2229321 [TBL] [Abstract][Full Text] [Related]
19. Treatment of acromegaly with octreotide: effectiveness and tolerability of its pulsatile administration by portable pump. Giusti M; Cuttica CM; Cariola G; Valenti S; Sessarego P; Giordano G Recenti Prog Med; 1995 May; 86(5):189-94. PubMed ID: 7604174 [TBL] [Abstract][Full Text] [Related]
20. A prospective examination of octreotide-induced gall-bladder changes in acromegaly. Eastman RC; Arakaki RF; Shawker T; Schock R; Roach P; Comi RJ; Gorden P Clin Endocrinol (Oxf); 1992 Mar; 36(3):265-9. PubMed ID: 1563079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]